Evidence map›Paper›PMID 40661854›Full record

ArticleFrontiers in chemistry2025

Metabolomics, antioxidant, and enzyme inhibitory effects of

Omayma A Eldahshan, Salwa Bouabdallah, Rawan M Abd El-Khalek, Mahmoud A El Hassab, Gokhan Zengin, Ahmed T Negmeldin, Eman F Khaleel, Wagdy M Eldehna, Nada M Mostafa

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Omayma A EldahshanDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Salwa BouabdallahEnvironmental Biomonitoring Laboratory LBE (LR01/ES14), Faculty of Sciences Bizerta, Carthage University, Zarzouna, Tunisia.
Rawan M Abd El-KhalekFaculty of Medicine, New Giza University, Giza, Egypt.
Mahmoud A El HassabDepartment of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), South Sinai, Egypt.
Gokhan ZenginDepartment of Biology, Science Faculty, Selcuk University, Konya, Türkiye.
Ahmed T NegmeldinDepartment of Pharmaceutical Sciences, College of Pharmacy and Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
Eman F KhaleelDepartment of Medical Physiology, College of Medicine, King Khalid University, Asir, Saudi Arabia.
Wagdy M EldehnaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
Nada M MostafaDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The genus Methods: We present herein the chemical composition of the hexane extracts of Results and Discussion: GC-MS revealed nootkatone (15.29%), decyl anthranilate (11.58%), neryl acetate (7.83%), and linalool acetate (6.83%) as major components of fruit extract; while the leaves extract contained mainly lupeol (24.32%), linalool (16.47%), friedelan-3-one (16.40%) and linalool acetate (12.31%). The extracts showed potential inhibitory activities against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), tyrosinase, amylase, and glucosidase enzymes. Results were confirmed by in silico molecular docking studies on the respective enzymes' active sites, viz NADPH oxidase, BChE, tyrosinase, α-amylase, and α-glucosidase. Amongst the docked compounds, lupeol showed the best binding affinities to NADPH oxidase, butyrylcholinesterase BChE, and α- glucosidase; while linalool acetate and neryl acetate showed the best activities against tyrosinase and α-amylase enzymes, respectively. In conclusion, bitter orange waste products can be a potentially important source of antioxidants and useful supplements.

Indexed as

antioxidantbitter orangeCitrus aurantiumenzyme inhibitionGC-MSRutaceae

Identifiers

PMID40661854
PMCPMC12257952

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.